933782-03-7

Basic information

• Product Name: (2-bromo-4-methylthiazol-5-yl)methanol
• Synonyms: (2-bromo-4-methylthiazol-5-yl)methanol
• CAS NO: 933782-03-7
• Molecular Weight: 208.079
• Mol File: 933782-03-7.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: (2-bromo-4-methylthiazol-5-yl)methanol(CAS DataBase Reference)
• NIST Chemistry Reference: (2-bromo-4-methylthiazol-5-yl)methanol(933782-03-7)
• EPA Substance Registry System: (2-bromo-4-methylthiazol-5-yl)methanol(933782-03-7)

Safety Data

• Hazardous Substances Data: 933782-03-7(Hazardous Substances Data)

Usage

General Description

(2-bromo-4-methylthiazol-5-yl)methanol is a chemical compound with the molecular formula C7H7BrNOS. It is a thiazole derivative and contains a bromine atom. (2-bromo-4-methylthiazol-5-yl)methanol has potential applications in medicinal chemistry and drug discovery due to its structural features and potential pharmacological properties. It may also be used as a building block in organic synthesis to develop new molecules with specific biological activities. Its unique structure and reactivity make it a valuable tool for researchers in various fields of science. Additionally, it is important to handle this compound with care due to its potentially harmful effects and toxicity.

Upstream product

• 22900-83-0 ethyl 2-bromo-4-methyl-1,3-thiazole-5-carboxylate 
• 7210-76-6 ethyl-2-amino-4-methylthiazole-5-carboxylate 

Downstream Products

• 1011532-51-6 (S)-ethyl 3-(4-((2-bromo-4-methylthiazol-5-yl)methoxy)phenyl)-3-(isoxazol-3-yl)propanoate 

Relevant articles and documents

NOVEL OXAZOLE AND THIAZOLE COMPOUNDS AS Β-CATENIN MODULATORS AND USES THEREOF

Heterocyclic compounds according to formula I: wherein A, B, Y, and Cy are as described herein, are provided as inhibitors of the Wnt pathway that specifically target the activity of the stabilized pool of B-cat. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, cancer, and other conditions related to Wnt pathway dysfunction, including various cancers and pulmonary fibrosis.

HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF DISEASES

The invention relates to compounds of Formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the present invention are useful in numerous diseases in which ALK protein is involved or in which inhibition of ALK activity may induce benefit, especially for the treatment of cancer mediated by a mutated EML4-ALK fusion protein.

Phenyl-1,2,4-Oxadiazolone Derivatives, Processes For Their Preparation and Methods For Their Use as Pharmaceuticals

The inventive compounds of the present invention are comprised of phenyl and pyridinyl-1,2,4-oxadiazolone derivatives and their physiologically acceptable salts and functional derivatives that are shown to provide peroxisome proliferator activator recepto